{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:41:56Z","timestamp":1769067716939,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/s1262-3636(07)70167-2","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T22:22:25Z","timestamp":1173392545000},"page":"55-62","source":"Crossref","is-referenced-by-count":152,"title":["Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome"],"prefix":"10.1016","volume":"31","author":[{"given":"M","family":"Valle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Martos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Gasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MA","family":"Zafra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1262-3636(07)70167-2_bib1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diabetes.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/S1262-3636(07)70167-2_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0026-0495(00)80047-5","article-title":"Infantile obesity: a situation of atherothrombotic risk?","volume":"49","author":"Valle","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/S1262-3636(07)70167-2_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/meta.2002.31319","article-title":"Metabolic cardiovascular syndrome in obese prepubertal children: the role of high fasting insulin levels","volume":"51","author":"Valle","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/S1262-3636(07)70167-2_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00403180","article-title":"Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome","volume":"34","author":"Ferrannini","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/S1262-3636(07)70167-2_bib5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/oxfordjournals.aje.a009572","article-title":"Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group","volume":"148","author":"Trevisan","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S1262-3636(07)70167-2_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S1262-3636(07)70167-2_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.ijo.0802260","article-title":"The metabolic syndrome is associated with elevated circulating C-reactive protein in helthy reference range, a systemic low-grade inflammatory state","volume":"27","author":"Tamakosshi","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S1262-3636(07)70167-2_bib8","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.23.12.1835","article-title":"Association between C-reactive protein and features of the metabolic syndrome: a population-based study","volume":"23","author":"Frohlich","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S1262-3636(07)70167-2_bib9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S1262-3636(07)70167-2_bib10","first-page":"S108","article-title":"Inflammation and atherosclerosis: the value of the high sensitive C-reactive protein assay as a risk marker","volume":"116","author":"Jialal","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S1262-3636(07)70167-2_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and the risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S1262-3636(07)70167-2_bib12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diabetes.51.4.1131","article-title":"Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study","volume":"51","author":"Festa","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S1262-3636(07)70167-2_bib13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S1262-3636(07)70167-2_bib14","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of Creactive protein and low-density lipoprotein cholesterol in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S1262-3636(07)70167-2_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S1262-3636(07)70167-2_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low inflammation and coronary heart disease: prospective study updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"B Med J"},{"key":"10.1016\/S1262-3636(07)70167-2_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syundrome, and risk of incident cardiovascular events: an 8year follow-up of 14719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/S1262-3636(07)70167-2_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/PL00013812","article-title":"Presence of metabolic cardiovascular syndrome in obese children","volume":"159","author":"Csabi","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S1262-3636(07)70167-2_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9150(99)00312-3","article-title":"C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors","volume":"149","author":"Cook","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/S1262-3636(07)70167-2_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.1999.tb07793.x","article-title":"Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances","volume":"892","author":"Matsuzawa","year":"1999","journal-title":"Ann NY Acd Sci"},{"key":"10.1016\/S1262-3636(07)70167-2_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.ijo.0802326","article-title":"Integrative physiology of human adipose tissue","volume":"27","author":"Frayn","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S1262-3636(07)70167-2_bib22","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.86.5.1930","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S1262-3636(07)70167-2_bib23","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1210\/jc.2002-020694","article-title":"Plasma adiponectin concentrations in children: relationships with obesity and insulinemia","volume":"87","author":"Stefan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S1262-3636(07)70167-2_bib24","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1210\/jc.2003-031925","article-title":"Adiponectin before and after weight loss in obese children","volume":"89","author":"Reinehr","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S1262-3636(07)70167-2_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-002-0378-7","article-title":"Adiponectin: a link between excess adiposity and associated comorbidities?","volume":"80","author":"Ukkola","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/S1262-3636(07)70167-2_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-2002-34785","article-title":"Adiponectin: its role in metabolism and beyond","volume":"34","author":"Stefan","year":"2002","journal-title":"Horm Metab Res"},{"key":"10.1016\/S1262-3636(07)70167-2_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bmj.313.7063.965","article-title":"Serum leptin concentration, obesity, and insulin resistance in Westerrn Samoans: cross sectional study","volume":"313","author":"Zimonet","year":"1996","journal-title":"B Med J"},{"key":"10.1016\/S1262-3636(07)70167-2_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1096-9136(199703)14:3<200::AID-DIA336>3.0.CO;2-V","article-title":"Hyperleptinaemia: the missing link in the metabolic syndrome?","volume":"14","author":"de Courten","year":"1997","journal-title":"Diabetic Med"},{"key":"10.1016\/S1262-3636(07)70167-2_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.ijo.0802154","article-title":"Relationship between high plasma leptin concentrations and metabolic syndrome in obese pre-pubertal children","volume":"27","author":"Valle","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S1262-3636(07)70167-2_bib30","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1161\/hc5001.101061","article-title":"Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS)","volume":"104","author":"Wallace","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S1262-3636(07)70167-2_bib31","series-title":"Fundaci\u00f3n Faustino Orbegozo","article-title":"Curvas y tablas de crecimiento. Instituto de Investigaci\u00f3n y Desarrollo","author":"Hern\u00e1ndez","year":"1988"},{"key":"10.1016\/S1262-3636(07)70167-2_bib32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/S1262-3636(07)70167-2_bib33","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/S1262-3636(07)70167-2_bib34","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S1262-3636(07)70167-2_bib35","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1542\/peds.107.1.e13","article-title":"Low-grade systemic inflammation in overweigt children","volume":"107","author":"Visser","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/S1262-3636(07)70167-2_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1067\/mpd.2001.112898","article-title":"C-reactive protein and body mass index in children: finding from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"138","author":"Ford","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/S1262-3636(07)70167-2_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0303-7207(96)03761-6","article-title":"Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells","volume":"118","author":"Crichton","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S1262-3636(07)70167-2_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1210\/jc.83.3.847","article-title":"Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid","volume":"83","author":"Fried","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S1262-3636(07)70167-2_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-128-2-199801150-00009","article-title":"The pathophysiologic roles of inteleukin-6 in human disease","volume":"128","author":"Papanicolaou","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1262-3636(07)70167-2_bib40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/1520-7560(200005\/06)16:3<192::AID-DMRR114>3.0.CO;2-G","article-title":"Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance","volume":"16","author":"Bastard","year":"2000","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S1262-3636(07)70167-2_bib41","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1161\/01.CIR.99.19.2496","article-title":"Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox","volume":"99","author":"Sobel","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S1262-3636(07)70167-2_bib42","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immuno system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/S1262-3636(07)70167-2_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/S1262-3636(07)70167-2_bib44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","article-title":"C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic andothelial cells: implications for the metabolic syndrome and atherothrombosis","volume":"107","author":"Devaraj","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/S1262-3636(07)70167-2_bib45","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1210\/jc.2004-0303","article-title":"Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels","volume":"89","author":"Bottner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S1262-3636(07)70167-2_bib46","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/diacare.27.8.2010","article-title":"Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes","volume":"27","author":"Morales","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S1262-3636(07)70167-2_bib47","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000041046.32962.86","article-title":"Differentiation between obesity and insulin resistance in the association with C-reactive protein","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363607701672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363607701672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T12:05:35Z","timestamp":1587384335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363607701672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1262363607701672"],"URL":"https:\/\/doi.org\/10.1016\/s1262-3636(07)70167-2","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}